To investigate the relationship between SLC7A11 expression and EMT progress during carcinogenesis, we performed immunohistochemistry in collected paraffin sections of tumors of 101 patients with breast cancer and matched adjacent normal tissues (Fig. 1A–D). This evidence concerns the gene SLC7A11 and breast carcinoma.